It also highlights a key difference between our study, which focused on non-nodular BCC (typically more aggressive and with higher mitotic counts), and the previous study, which identified greater SMO expression in SEB than in nodular BCC15. The gene discussed is SMO; the disease is skin basal cell carcinoma.